AKR1D1基因复合杂合变异所致先天性胆汁酸合成障碍2型一个家系的临床及遗传学分析

吴颖; 王梅; 洪志丹; 李桂桂; 张铭

doi:10.14188/j.1671-8852.2024.0101

您当前的位置：

首页 >

文章列表页 >

AKR1D1基因复合杂合变异所致先天性胆汁酸合成障碍2型一个家系的临床及遗传学分析

临床医学研究 | 更新时间：2026-11-05

- AKR1D1基因复合杂合变异所致先天性胆汁酸合成障碍2型一个家系的临床及遗传学分析
- Clinical and genetic analysis of a family affected by congenital bile acid synthesis disorder type 2 caused by complex heterozygous variation of AKR1D1 gene
- 武汉大学学报（医学版） 2025年46卷第6期页码：799-805
- 作者机构：
  
  武汉大学中南医院生殖医学中心湖北武汉 430071
- 作者简介：
  
  吴颖，女，1998—，医学硕士，主要从事生殖健康的研究，E⁃mail: 2021283030193@whu.edu.cn
  张铭，女，1979—，医学博士，副教授，主任医师，主要从事生殖医学、优生优育的研究，E⁃mail: whu_mz@163.com
- 基金信息：
- DOI：10.14188/j.1671-8852.2024.0101
  中图分类号： R394.1
- 收稿：2024-02-11，
  
  纸质出版：2025-06-25
- 稿件说明：
移动端阅览
吴颖,王梅,洪志丹等.AKR1D1基因复合杂合变异所致先天性胆汁酸合成障碍2型一个家系的临床及遗传学分析[J].武汉大学学报（医学版）,2025,46(06):799-805.

WU Ying,WANG Mei,HONG Zhidan,et al.Clinical and genetic analysis of a family affected by congenital bile acid synthesis disorder type 2 caused by complex heterozygous variation of AKR1D1 gene[J].Medical Journal of Wuhan University,2025,46(06):799-805.
吴颖,王梅,洪志丹等.AKR1D1基因复合杂合变异所致先天性胆汁酸合成障碍2型一个家系的临床及遗传学分析[J].武汉大学学报（医学版）,2025,46(06):799-805. DOI： 10.14188/j.1671-8852.2024.0101.

WU Ying,WANG Mei,HONG Zhidan,et al.Clinical and genetic analysis of a family affected by congenital bile acid synthesis disorder type 2 caused by complex heterozygous variation of AKR1D1 gene[J].Medical Journal of Wuhan University,2025,46(06):799-805. DOI： 10.14188/j.1671-8852.2024.0101.

摘要

目的

探讨一例AKR1D1基因变异导致的先天性胆汁酸合成障碍2型家系的临床表现及遗传学特征，为家系的遗传咨询和变异携带者的助孕策略提供指导。

方法

选择2023年7月因“先天性胆汁酸合成障碍患儿生育史”而就诊于武汉大学中南医院的一个家系，收集其临床资料，对患儿先证者及其父母外周血进行全外显子测序，先证者进行遗传学变异检测，利用Sanger测序对其家系成员验证相关基因变异位点，并对变异位点的氨基酸保守性及变异对蛋白质功能的影响进行生物信息学分析。根据美国医学遗传学与基因组协会基因变异解读标准和指南(ACMG)对变异位点进行致病性评级。

结果

全外显子测序结果提示先证者AKR1D1基因存在父源c.580⁃13T>A和母源c.78C>A (p.Tyr26*)复合杂合变异，且c.78C>A (p.Tyr26*)为未见报道的新变异。生物信息学软件预测两位点变异均为有害变异，且在不同物种中高度保守。根据ACMG指南，AKR1D1 c.78C>A (p.Tyr26*)和c.580⁃13T>A均被评为致病变异（PVS1+PM2+PM3+PP4；PS3+PM2+PM3_Strong +PP4），并可为后续的生育方式及生殖遗传阻断提供指导。

结论

AKR1D1

c.78C

A (p.Tyr26*)；c.580⁃13T

A新复合杂合致病变异可能是先证者的致病原因。上述发现丰富了CBAS2的变异谱，并为该家系的诊断、遗传咨询和助孕策略提供了指导和帮助。

Abstract

Objectives

To explore the clinical and genetic features of a family affected by congenital bile acid synthesis disorder type 2 caused by AKR1D1 gene variation

and to provide genetic counseling for the family and the assisted reproductive strategy for the mutation carrier.

Methods

A family was selected from Zhongnan Hospital of Wuhan University in July 2023 due to "fertility history of children with congenital bile acid synthesis disorder". Clinical data were collected

and peripheral blood samples were collected from the patient and his parents. Whole⁃exome sequencing was used to detect genetic variants in the proband

and Sanger sequencing was used to verify related gene variants in family members. The conservation of amino acids and the effects of variations on protein function were analyzed using bioinformatics. The pathogenicity of the variants was evaluated according to the American College of Medical Genetics and Genomics (ACMG) variant interpretation standards and guidelines.

Results

Whole⁃exome sequencing showed that the proband carried compound heterozygous mutations of the AKR1D1 gene

c.580⁃13T>A from his father and c.78C>A (p.Tyr26*) from his mother

and c.78C>A (p.Tyr26*) was a novel variant. Bioinformatics software to predict both variants for harmful mutations

and highly conserved across different species. According to ACMG guidelines

78C>A (p. Tyr26*) and c. 580⁃13T>A of AKR1D1 were both rated as pathogenic variants (PVS1+PM2+PM3+PP4; PS3+PM2+PM3_Strong+PP4)

and can guide the subsequent reproductive mode and reproductive genetic block.

Conclusion

AKR1D1 c.78C>A (p.Tyr26*). A novel compound heterozygous variant c.580⁃13T>A probably underlay the disease in the proband. These findings enrich the mutation spectrum of CBAS2

and provide guidance and help for the diagnosis

genetic counseling and assisted pregnancy strategy of this family.

关键词

Keywords

references

MIZUOCHI T , TAKEI H , NITTONO H , et al . Inborn errors of bile acid metabolism in Japan [J ] . Pediatr Int , 2023 , 65 ( 1 ): e15490 .

SUNDARAM S S , BOVE K E , LOVELL M A , et al . Mechanisms of disease: Inborn errors of bile acid synthesis [J ] . Nat Clin Pract Gastroenterol Hepatol , 2008 , 5 ( 8 ): 456 ⁃ 468 .

CHENG Y , GUO L , DENG M , et al . Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: Identification of 2 novel mutations in AKR1D1 gene [J ] . Chin Jour Conte Pediatrics , 2017 , 19 ( 7 ): 734 ⁃ 740 .

JANKOWSKA I , SOCHA P . Progressive familial intrahepatic cholestasis and inborn errors of bile acid synthesis [J ] . Clin Res Hepatol Gastroenterol , 2012 , 36 ( 3 ): 271 ⁃ 274 .

CHEN M , PENNING T M . 5beta⁃Reduced steroids and human Delta(4)⁃3⁃ketosteroid 5beta⁃reductase (AKR1D1) [J ] . Steroids , 2014 , 83 : 17 ⁃ 26 .

DRURY J E , MINDNICH R , PENNING T M . Characterization of disease⁃related 5beta⁃reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency [J ] . J Biol Chem , 2010 , 285 ( 32 ): 24529 ⁃ 24537 .

RICHARDS S , AZIZ N , BALE S , et al . Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology [J ] . Genet Med , 2015 , 17 ( 5 ): 405 ⁃ 424 .

DAUGHERTY C C , SETCHELL K D , HEUBI J E , et al . Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4⁃3⁃oxosteroid 5 beta⁃reductase deficiency) [J ] . Hepatology , 1993 , 18 ( 5 ): 1096 ⁃ 1101 .

JIA W , LI Y , CHEUNG K , et al . Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis [J ] . Sci China Life Sci , 2024 , 67 ( 5 ): 865 ⁃ 878 .

SUNDARAM S S , BOVE K E , LOVELL M A , et al . Mechanisms of disease: Inborn errors of bile acid synthesis [J ] . Nat Clin Pract Gastroenterol Hepatol , 2008 , 5 ( 8 ): 456 ⁃ 468 .

CHEN M , JIN Y , PENNING T M . The rate⁃determining steps of aldo⁃keto reductases (AKRs), a study on human steroid 5beta⁃reductase (AKR1D1) [J ] . Chem Biol Interact , 2015 , 234 : 360 ⁃ 365 .

CHEN M , JIN Y , PENNING T M . In⁃depth dissection of the P133R mutation in steroid 5beta⁃reductase (AKR1D1): A molecular basis of bile acid deficiency [J ] . Biochemistry , 2015 , 54 ( 41 ): 6343 ⁃ 6351 .

HEUBI J E , SETCHELL K , BOVE K E . Inborn errors of bile acid metabolism [J ] . Clin Liver Dis , 2018 , 22 ( 4 ): 671 ⁃ 687 .

PHAM A N , THI K B , THI M N , et al . Clinical and genetic features of congenital bile acid synthesis defect with a novel mutation in AKR1D1 gene sequencing: Case reports [J ] . Medicine (Baltimore) , 2022 , 101 ( 25 ): e29476 .

JIN Y , CHEN M , PENNING T M . Rate of steroid double⁃bond reduction catalysed by the human steroid 5beta⁃reductase (AKR1D1) is sensitive to steroid structure: Implications for steroid metabolism and bile acid synthesis [J ] , Biochem J , 2014 , 462 ( 1 ): 163 ⁃ 171 .

SETCHELL K D , SUCHY F J , WELSH M B , et al . Delta 4⁃3⁃oxosteroid 5 beta⁃reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis [J ] . J Clin Invest , 1988 , 82 ( 6 ): 2148 ⁃ 2157 .

LEMONDE H A , CUSTARD E J , BOUQUET J , et al . Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)⁃3⁃oxosteroid 5beta⁃reductase, in hepatitis and liver failure in infancy [J ] . Gut , 2003 , 52 ( 10 ): 1494 ⁃ 1499 .

PALERMO M , MARAZZI M G , HUGHES B A , et al . Human Delta4⁃3⁃oxosteroid 5beta⁃reductase (AKR1D1) deficiency and steroid metabolism [J ] . Steroids , 2008 , 73 ( 4 ): 417 ⁃ 423 .

GARDIN A , RUIZ M , BEIME J , et al . ∆(4)⁃3⁃oxo⁃5beta⁃reductase deficiency: Favorable outcome in 16 patients treated with cholic acid [J ] . Orphanet J Rare Dis , 2023 , 18 ( 1 ): 383 .

ZHAO J , QIU Y L , WANG L , et al . Recurrent AKR1D1 c.580⁃13T>A variant: A cause of Delta(4)⁃3⁃Oxosteroid⁃5beta⁃reductase deficiency [J ] . J Mol Diagn , 2023 , 25 ( 4 ): 227 ⁃ 233 .

PARIKH F , ATHALYE A , MADON P , et al . Genetic counseling for pre⁃implantation genetic testing of monogenic disorders (PGT⁃M) [J ] . Front Reprod Health , 2023 , 5 : 1213546 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

298例遗传咨询病人的染色体分析

常春藤皂苷元对压力超负荷诱导的小鼠心肌肥厚及纤维化的影响

胸外科成人患者声带麻痹原因分析

核因子红细胞2相关因子2在缺血性脑卒中的机制和相关防治价值

高通量测序临床报告中遗传变异正交实验验证的规范化建议